MedPath
NMPA Approval

Lanadelumab Injection

国药准字SJ20255003

May 9, 2025

国药准字SJ20200025

Drug Information

拉那利尤单抗注射液

达泽优

注射剂

300mg/2ml(150mg/ml)(预充式)

生物制品

May 9, 2025

December 1, 2025

Company Information

Applicant Company

95 Hayden Avenue, Lexington, MA 02421, United States of America

Manufacturing Company

Schützenstraße 87 and 99-101, 88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉那利尤单抗注射液 - NMPA 批准文号 | MedPath